Related Experiment Videos

A diabetes scorecard does not improve HbA(1c), blood pressure, lipids, aspirin usage, exercise and diabetes knowledge

M S Irwig1, P Sood, D Ni

  • 1Department of Medicine, George Washington University, Washington, DC, USA. mirwig@mfa.gwu.edu

Diabetic Medicine : a Journal of the British Diabetic Association
|February 16, 2012
PubMed

Insights

A diabetes scorecard did not improve health outcomes for Type 2 diabetes patients. Neither the scorecard nor usual care significantly improved glycaemic control, blood pressure, or cholesterol levels.

Area of Science:

  • Endocrinology
  • Public Health
  • Clinical Medicine

Background:

  • Type 2 diabetes management requires continuous monitoring and patient engagement.
  • Clinical inertia, a barrier to optimal diabetes care, necessitates innovative patient- and physician-focused interventions.
  • Assessing the impact of patient-facing tools on managing chronic conditions is crucial for improving health outcomes.

Purpose of the Study:

  • To evaluate the efficacy of a diabetes scorecard in enhancing glycaemic control, blood pressure, LDL cholesterol, aspirin use, and exercise.
  • To determine if the scorecard motivates or educates patients for improved self-management.
  • To assess the scorecard's effect on reducing clinical inertia in Type 2 diabetes care.

Main Methods:

  • A randomized controlled trial involving 103 adult patients with uncontrolled Type 2 diabetes.
  • Patients received either a diabetes scorecard or standard care over nine months and four clinical visits.
  • The scorecard assigned points based on six clinical variables, aiming for a perfect score of 100.

Main Results:

  • No significant differences were observed between the scorecard and control groups in total score, HbA1c, blood pressure, LDL cholesterol, aspirin usage, exercise, or knowledge at nine months.
  • Both groups showed statistically significant improvements in mean total score and HbA1c by the final visit.
  • While both groups improved, the scorecard did not demonstrate superior outcomes compared to standard care.

Conclusions:

  • A diabetes scorecard did not significantly improve glycaemic control, blood pressure, LDL cholesterol, aspirin usage, exercise, or diabetic knowledge in urban adults with uncontrolled Type 2 diabetes.
  • Both the intervention and control groups experienced improvements, suggesting other factors may influence patient outcomes.
  • The study highlights the need for further research into effective strategies for managing Type 2 diabetes and overcoming clinical inertia.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...